First Line Drug Therapy for Type 2 Diabetes
Listen now
Dr. Centor discusses the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes with Drs. Neda Laiteerapong and Aaron Winn.
More Episodes
Published 09/18/23
Dr. Centor discusses the risk for anemia in older patients receiving aspirin for primary prevention with Dr. Zoe McQuilten.
Published 09/18/23
Dr. Centor discusses issues of physician turnover and the need to keep physicians in the workforce with Dr. Eileen Barrett.
Published 09/04/23